The long-term natural history of the weekly symptomatic status of bipolar I disorder
- PMID: 12044195
- DOI: 10.1001/archpsyc.59.6.530
The long-term natural history of the weekly symptomatic status of bipolar I disorder
Abstract
Background: To our knowledge, this is the first prospective natural history study of weekly symptomatic status of patients with bipolar I disorder (BP-I) during long-term follow-up.
Methods: Analyses are based on ongoing prospective follow-up of 146 patients with Research Diagnostic Criteria BP-I, who entered the National Institute of Mental Health (Bethesda, Md) Collaborative Depression Study from 1978 through 1981. Weekly affective symptom status ratings were analyzed by polarity and severity, ranging from asymptomatic, to subthreshold levels, to full-blown major depression and mania. Percentages of follow-up weeks at each level as well as number of shifts in symptom status and polarity during the entire follow-up period were examined. Finally, 2 new measures of chronicity were evaluated in relation to previously identified predictors of chronicity for BP-I.
Results: Patients with BP-I were symptomatically ill 47.3% of weeks throughout a mean of 12.8 years of follow-up. Depressive symptoms (31.9% of total follow-up weeks) predominated over manic/hypomanic symptoms (8.9% of weeks) or cycling/mixed symptoms (5.9% of weeks). Subsyndromal, minor depressive, and hypomanic symptoms combined were nearly 3 times more frequent than syndromal-level major depressive and manic symptoms (29.9% vs 11.2% of weeks, respectively). Patients with BP-I changed symptom status an average of 6 times per year and polarity more than 3 times per year. Longer intake episodes and those with depression-only or cycling polarity predicted greater chronicity during long-term follow-up, as did comorbid drug-use disorder.
Conclusions: The longitudinal weekly symptomatic course of BP-I is chronic. Overall, the symptomatic structure is primarily depressive rather than manic, and subsyndromal and minor affective symptoms predominate. Symptom severity levels fluctuate, often within the same patient over time. Bipolar I disorder is expressed as a dimensional illness featuring the full range (spectrum) of affective symptom severity and polarity.
Similar articles
-
A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.Arch Gen Psychiatry. 2003 Mar;60(3):261-9. doi: 10.1001/archpsyc.60.3.261. Arch Gen Psychiatry. 2003. PMID: 12622659
-
Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study.Arch Gen Psychiatry. 2005 Dec;62(12):1322-30. doi: 10.1001/archpsyc.62.12.1322. Arch Gen Psychiatry. 2005. PMID: 16330720
-
Long-term symptomatic status of bipolar I vs. bipolar II disorders.Int J Neuropsychopharmacol. 2003 Jun;6(2):127-37. doi: 10.1017/S1461145703003341. Int J Neuropsychopharmacol. 2003. PMID: 12890306 Clinical Trial.
-
ECNP consensus meeting. Bipolar depression. Nice, March 2007.Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Eur Neuropsychopharmacol. 2008. PMID: 18501566 Review.
-
Prepubertal and early adolescent bipolar I disorder: review of diagnostic validation by Robins and Guze criteria.J Clin Psychiatry. 2005;66 Suppl 7:21-8. J Clin Psychiatry. 2005. PMID: 16124838 Review.
Cited by
-
A Smartphone-Based Self-management Intervention for Bipolar Disorder (LiveWell): User-Centered Development Approach.JMIR Ment Health. 2021 Apr 12;8(4):e20424. doi: 10.2196/20424. JMIR Ment Health. 2021. PMID: 33843607 Free PMC article.
-
Evidence for avolition in bipolar disorder? A 30-day ecological momentary assessment comparison of daily activities in bipolar disorder and schizophrenia.Psychiatry Res. 2021 Jun;300:113924. doi: 10.1016/j.psychres.2021.113924. Epub 2021 Apr 4. Psychiatry Res. 2021. PMID: 33848963 Free PMC article.
-
Designing and testing of a health-economic Markov model to assess the cost-effectiveness of treatments for Bipolar disorder: TiBipoMod.Front Psychiatry. 2022 Nov 10;13:1030989. doi: 10.3389/fpsyt.2022.1030989. eCollection 2022. Front Psychiatry. 2022. PMID: 36440423 Free PMC article.
-
Efficacy of quetiapine in patients with bipolar I and II depression: a multicenter, prospective, open-label, observational study.Neuropsychiatr Dis Treat. 2013;9:197-204. doi: 10.2147/NDT.S41081. Epub 2013 Feb 8. Neuropsychiatr Dis Treat. 2013. PMID: 23431086 Free PMC article.
-
Clinical characteristics and functioning of adults with bipolar I disorder: Evidence from the mental and substance use disorders prevalence study.J Affect Disord. 2024 Dec 1;366:317-325. doi: 10.1016/j.jad.2024.08.133. Epub 2024 Aug 25. J Affect Disord. 2024. PMID: 39191309
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical